《大动脉炎诊断和治疗中国指南（2023年版）》
Chinese guideline for the diagnosis and treatment of Takayasu's arteritis (2023).
作者信息
Tian Xinping, Zeng Xiaofeng
机构信息
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science& Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.
出版信息
Rheumatol Immunol Res. 2024 Mar 31;5(1):5-26. doi: 10.1515/rir-2024-0002. eCollection 2024 Mar.
Takayasu's arteritis (TAK) is a chronic granulomatous inflammatory disease that involves aorta and its primary branches. It is characterized by wall thickening, stenosis/obliteration or aneurysm formation of the involved arteries. In order to standardize the diagnosis and treatment of TAK in China, a clinical practice guideline with an evidence-based approach is developed under the leadership of National Clinical Medical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID). Eleven recommendations for 11 clinical questions that are important to the diagnosis and treatment of TAK are developed based on the latest evidence and expert opinions combined with real clinical practice in China.
大动脉炎（TAK）是一种慢性肉芽肿性炎症性疾病，累及主动脉及其主要分支。其特征为受累动脉壁增厚、狭窄/闭塞或形成动脉瘤。为规范我国大动脉炎的诊断与治疗，在国家皮肤与免疫疾病临床医学研究中心（NCRC-DID）的领导下，制定了一项基于循证医学方法的临床实践指南。基于最新证据、专家意见并结合我国实际临床实践，针对大动脉炎诊断和治疗中重要的11个临床问题制定了11条推荐意见。
Zotero 插件